Table 1.
Frequency in |
||||||
Markera | Distanceb(bp) | Location | Allele | EJM1+ | Control | OR (95% CI)c |
rs11244 | 0 | HLA-DOB | C/t | .82 | .75 | 1.51 (.61–3.68) |
rs241441 | 5,070 | ABCB3 | C/t | .40 | .37 | 1.15 (.56–2.36) |
rs1057141 | 37,989 | ABCB2 | G/a | .85 | .84 | 1.09 (.41–2.85) |
rs1044244 | 44,329 | PSMB9 | T/c | .28 | .26 | 1.08 (.49–2.38) |
rs241412 | 80,879 | … | T/g | .43 | .34 | 1.44 (.70–2.97) |
rs10751 | 121,762 | HLA-DMB | T/c | .25 | .13 | 2.14 (.90–5.08) |
rs2071556 | 123,780 | HLA-DMB | C/a | .55 | .36 | 2.19 (1.07–4.50) |
rs206787 | 162,081 | BRD2 promoter | T/a | .53 | .33 | 2.21 (1.08–4.52) |
rs3918149 | 162,216 | BRD2 promoter | T/c | .29 | .13 | 2.80 (1.19–6.64) |
rs620202 | 161,048 | BRD2 intron 1 | G/t | .85 | .72 | 2.16 (.85–5.46) |
rs516535 | 161,524 | BRD2 exon 2 | C/t | .48 | .31 | 2.05 (1.00–4.22) |
rs635688 | 162,370 | BRD2 intron 2 | T/c | .53 | .34 | 2.16 (1.05–4.42) |
rs2066741 | 163,304 | BRD2 intron 5 | T/c | .68 | .45 | 2.51 (1.20–5.24) |
rs206781 | 165,351 | BRD2 exon 9 | T/c | .70 | .65 | 1.27 (.59–2.69) |
rs206777 | 171,733 | … | C/t | .50 | .30 | 2.29 (1.11–4.71) |
rs497058 | 176,049 | … | T/c | .51 | .34 | 2.08 (1.01–4.28) |
rs1044429 | 191,853 | … | C/t | .85 | .81 | 1.33 (.51–3.44) |
rs2581 | 193,612 | HLA-DNA | T/g | .43 | .33 | 1.48 (.72–3.05) |
rs365066 | 194,349 | HLA-DNA | T/c | .40 | .33 | 1.35 (.65–2.80) |
rs375256 | 195,031 | HLA-DNA | T/c | .79 | .75 | 1.22 (.50–2.99) |
Markers are listed in order from DQ to DP.
Distances are measured from the first SNP marker, rs11244.
Statistically significant associations are underlined. These associated SNPs span the HLA-DMB gene, the BRD2 (RING3) gene, and promoter region.